184 related articles for article (PubMed ID: 18165616)
1. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas.
Lefranc F; Facchini V; Kiss R
Oncologist; 2007 Dec; 12(12):1395-403. PubMed ID: 18165616
[TBL] [Abstract][Full Text] [Related]
2. Autophagy, the Trojan horse to combat glioblastomas.
Lefranc F; Kiss R
Neurosurg Focus; 2006 Apr; 20(4):E7. PubMed ID: 16709038
[TBL] [Abstract][Full Text] [Related]
3. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
Lefranc F; Rynkowski M; DeWitte O; Kiss R
Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
[TBL] [Abstract][Full Text] [Related]
4. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
5. Glucosylceramide synthase protects glioblastoma cells against autophagic and apoptotic death induced by temozolomide and Paclitaxel.
Giussani P; Bassi R; Anelli V; Brioschi L; De Zen F; Riccitelli E; Caroli M; Campanella R; Gaini SM; Viani P; Riboni L
Cancer Invest; 2012 Jan; 30(1):27-37. PubMed ID: 22236187
[TBL] [Abstract][Full Text] [Related]
6. [Glioblastomas are resistant to apoptosis but less resistant to the autophagic process].
Lefranc F
Bull Mem Acad R Med Belg; 2007; 162(5-6):331-8. PubMed ID: 18405003
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of proapoptotic and autophagic proteins involved in the cell death of glioblastoma induced by synthetic glycans.
Faried A; Arifin MZ; Ishiuchi S; Kuwano H; Yazawa S
J Neurosurg; 2014 Jun; 120(6):1298-308. PubMed ID: 24678780
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic exploitation of apoptosis and autophagy for glioblastoma.
Kögel D; Fulda S; Mittelbronn M
Anticancer Agents Med Chem; 2010 Jul; 10(6):438-49. PubMed ID: 20879985
[TBL] [Abstract][Full Text] [Related]
9. Evidence of galectin-1 involvement in glioma chemoresistance.
Le Mercier M; Lefranc F; Mijatovic T; Debeir O; Haibe-Kains B; Bontempi G; Decaestecker C; Kiss R; Mathieu V
Toxicol Appl Pharmacol; 2008 Jun; 229(2):172-83. PubMed ID: 18313712
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis-modulating drugs for improved cancer therapy.
Ocker M; Höpfner M
Eur Surg Res; 2012; 48(3):111-20. PubMed ID: 22538523
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways.
Zhang L; Wang H; Xu J; Zhu J; Ding K
Toxicol Lett; 2014 Aug; 228(3):248-59. PubMed ID: 24875536
[TBL] [Abstract][Full Text] [Related]
12. Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: implications for future therapeutic approaches.
Schleicher SM; Moretti L; Varki V; Lu B
Drug Resist Updat; 2010 Jun; 13(3):79-86. PubMed ID: 20471904
[TBL] [Abstract][Full Text] [Related]
13. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.
Mégalizzi V; Mathieu V; Mijatovic T; Gailly P; Debeir O; De Neve N; Van Damme M; Bontempi G; Haibe-Kains B; Decaestecker C; Kondo Y; Kiss R; Lefranc F
Neoplasia; 2007 May; 9(5):358-69. PubMed ID: 17534441
[TBL] [Abstract][Full Text] [Related]
14. Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers.
Law BY; Mok SW; Chan WK; Xu SW; Wu AG; Yao XJ; Wang JR; Liu L; Wong VK
Oncotarget; 2016 Feb; 7(7):8090-104. PubMed ID: 26811496
[TBL] [Abstract][Full Text] [Related]
15. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.
Mathieu V; Le Mercier M; De Neve N; Sauvage S; Gras T; Roland I; Lefranc F; Kiss R
J Invest Dermatol; 2007 Oct; 127(10):2399-410. PubMed ID: 17495956
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.
Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S
Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851
[TBL] [Abstract][Full Text] [Related]
17. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.
Lefranc F; Brotchi J; Kiss R
J Clin Oncol; 2005 Apr; 23(10):2411-22. PubMed ID: 15800333
[TBL] [Abstract][Full Text] [Related]
18. Autophagy in cancer and chemotherapy.
Yousefi S; Simon HU
Results Probl Cell Differ; 2009; 49():183-90. PubMed ID: 19142622
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cell sensitivity to antitumor agents by targeting survival pathways.
Perego P; Cossa G; Zuco V; Zunino F
Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050
[TBL] [Abstract][Full Text] [Related]
20. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.
Golden EB; Cho HY; Hofman FM; Louie SG; Schönthal AH; Chen TC
Neurosurg Focus; 2015 Mar; 38(3):E12. PubMed ID: 25727221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
